Why the study?
Is fenfluramine-phentermine therapy associated with valvular heart disease?
Is fenfluramine-phentermine therapy associated with valvular heart disease?
Fenfluramine-phentermine therapy raises significant safety concerns regarding the development of valvular heart disease and pulmonary hypertension.
May warrant caution with fenfluramine-phentermine; leaves open confirmation of valvular risks in larger studies.
These cases arouse concern that fenfluramine-phentermine therapy may be associated with valvular heart disease. Candidates for fenfluramine-phentermine therapy should be informed about serious potential adverse effects, including pulmonary hypertension and valvular heart disease.
No takes yet. Share an insight, caveat, or question.
Connolly et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: